Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4317-4324

  Giatromanolaki, Alexandra ^a   Harris, Adrian L ^a  

^a Tumour and Angiogenesis Research Group Iraklion   (Greece)

Author keywords

Cancer; Hypoxia; Hypoxia inducible factors

Indexed keywords

ANGIOGENESIS INHIBITOR; BLEOMYCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IODINE DERIVATIVE; MISONIDAZOLE; NITRIC OXIDE SYNTHASE INHIBITOR; OLIGONUCLEOTIDE; PIMONIDAZOLE; PRODRUG; RADIOSENSITIZING AGENT; TIRAPAZAMINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR;

CANCER; CANCER GROWTH; CANCER RESISTANCE; CANCER THERAPY; CELL METABOLISM; ERYTHROPOIESIS; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN TISSUE; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN DNA BINDING; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035573998     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. The action of radium on cancer cells. I. II. Some factors determining the susceptibility of cancer cells to radium
2. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
3. The histological stracture of some human lung cancers and the possible implication in radiotherapy
4. Hypoxic fractions of solid tumours: Experimental techniques, methods of analysis and survey of existing data
5. Fighting cancer by attacking its blood supply
6. Tumour angiogenesis and metastasis - Correlation in invasive breast carcinoma
7. Invading edge vs. inner (edvin) patterns of vascularisation: An interplay between angiogenic and vascular survival factors defines clinical behaviour of non small cell lung cancer
8. Heterogeneity of angiogenesis and blood vessel maturation in human tumours: Implications for antiangiogenic tumour therapies
9. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts
10. The Nobel chronicles. 1931. Otto Heinrich Warburg (1883-1970)
11. Tumour hypoxia and the positron paradox
12. The molecular basis of hypoxia response pathway: Tumour hypoxia as a therapy target
13. Von-Hippel-Lindau syndrome target for anti-vascular endothelial growth factor (VEGF) receptor therapy
14. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
15. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2
16. Loss of PTEN facilitates HIF-1-mediated gene expression
17. Measurement of tumour hypoxia by invasive and non-invasive procedures: A review of the recent clinical studies
18. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy
19. Oxygenation predicts radiation response and survival in patients with cervix cancer
20. Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix
21. The phenomenon of reoxygenation and its implications for fractionated radiotherapy
22. Changes in oxygenation during radiotherapy in carcinoma of the cervix
23. Evaluation of oxygenation status during fractionated radiotherapy in human non small cell lung cancers using [F-18]fluoromisonidazole positron emission tomography
24. Microvascular and tumour cell alterations during continuous hyperfractionated irradiation: An electron microscopic investigation on the rat R1H rhabdomyosarcoma
25. Taxane-induced apoptosis decompresses blood vessels an lowers interstitial fluid pressure in solid tumours: Clinical implications
26. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
27. Angioegenesis in the hollow fiber tumour model influences drug delivery to tumour cells: Implications for anticancer drug screening programs
28. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines
29. Thioredoxin and thioredoxin reductase gene expression in human tumours and cell lines, and the effects of serum stimulation and hypoxia
30. Possible roles of an adult T-cell leukemia (ATL)-derived factor/thioredoxin in the drug resistance of ATL to adriamycin
31. Mechanism of heat shock protein 72 induction in primary cultured astrocytes after oxygen-glucose deprivation
32. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumour cells
33. Tumour-derived expression of vascular endothelial growth factor is a critical factor in tumour expansion and vascular function
34. Thymidine phosphorylase expression is associated with both increase of intratumoural microvessels and decrease of apoptosis in human colorectal carcinomas
35. The effect of thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumours
36. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro
37. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumour angiogenesis
38. The influence of oxygen-tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast-tumour cells grown in vitro and in vivo
39. Tumour oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
40. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterin cervix
41. Mechanisms and therapeutic implications of angiogenesis
42. Regulation of the erythropoietin gene: Evidence that oxygen sensor is a heme protein
43. 2 sensing
44. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes
45. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin
46. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
47. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1a regulates the VEGF expression and is potentially involved in lung and vascular development
48. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells
49. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
50. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
51. Purification and characterization of hypoxia-inducible factor 1
52. 2 tension
53. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1a regulates the VEGF expression and is potentially involved in lung and vascular development
54. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha
55. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
56. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1a
57. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
58. 2-dependent degradation domain via the ubiquitine-proteasome pathway
59. Molecular mechanisms of transcription activation by HLF and HIF1a in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
60. An essent p300/CBP in the cellular response to hypoxia
61. Hypoxia-inducible factor 1a (HIF-1a) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions
62. Cadmium blocks hypoxia inducible factor HIF-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha
63. Von Hippel Lindau syndrom: A pleiomorphic condition
64. One ring to rule a superfamily of E3 ubiquitine ligases
65. Structure of the VHL-elonginC-ElonginB complex: Implications for VHL tumour suppressor function
66. Clinical features and natural history of von Hippel-Lindau disease
67. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
68. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2
69. Loss of PTEN facilitates HIF-1-mediated gene expression
70. Non-hypoxic pathway mediates the induction of hypoxia inducible factor 1 alpha (HIF-1a) in vascular smooth muscle cells
71. Age-dependent defect in VEGF expression is associated with reduced HIF-1 activity
72. Hypoxia, HIF-1, and the pathophysiology of common human disease
73. Overexpression of hypoxia-inducible factor 1a in common human cancers and their metastases
74. Expression of hypoxia-inducible factor 1alpha in brain tumours: Association with angiogenesis, invasion, and progression
75. The expression and distribution of the hypoxia inducible factors HIF-1a and HIF-2a in normal human tissues, cancers and tumour associated macrophages
76. Results of an RTOG phase and trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas
77. Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation
78. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia
79. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
80. UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response